This enables the measuring accuracy of the blood pressure watch to be increased by more than 70 per cent. Clinical trials of the device are currently under way. The first measurements have already been taken in parallel with a catheter procedure - with very promising results.
After menopause, a woman's risk of high blood pressure and other cardiovascular diseases increases greatly; the risk increases significantly faster for women after hysterectomy, perhaps because the uterus produces chemicals that help regulate blood pressure.
Women who are insulin resistant are at much greater risk of obesity, diabetes, hypertension (high blood pressure), heart disease, high cholesterol, breast cancer and polycystic ovarian syndrome (PCOS). There is some evidence that insulin resistance may contribute to endometrial cancer.